Grid Therapeutics
Last updated: April 17, 2024
Edward (Ned) Patz, CEO & Co-Founder
Country: USA | Funding: $5M (+)
Website: https://gridtherapeutics.com
Grid is developing the first human derived targeted immunotherapy for cancer.
Website: https://gridtherapeutics.com
Grid is developing the first human derived targeted immunotherapy for cancer.